EGR1 and breast carcinoma: Approximately 30% more cells of the macrophage subtypes positive for LAM2_APOE, LAM1_FABP5 and EGR1, respectively, expressed CLEC10A in TNBC in comparison with ER+ / HER2+ breast cancer (Chi-squared p < 0.001, Table S4).